Osteoboost in the news

Osteoboost, the FDA-cleared vibrating wearable designed to combat bone density loss, is manufactured in Medford, Oregon.

KTLA covers Osteoboost, the FDA‑cleared wearable belt using vibration therapy to strengthen bones and help prevent osteoporosis in postmenopausal women.

Discover expert tips on maintaining bone health, including the role of innovative therapies like Osteoboost, in this Seattle Times feature.

The Mercury News highlights Osteoboost, a NASA-inspired wearable that reduces bone fracture risk through low-vibration therapy.

CEO Laura Yecies discusses Osteoboost, the FDA-cleared, drug-free wearable combating bone loss in postmenopausal women.

Orthopedics This Week reports on FDA clearance of Osteoboost, a wearable device using low-intensity vibrations to strengthen bones and prevent osteoporosis.

Medical Economics details Osteoboost's nationwide launch, an FDA-cleared wearable using vibration therapy to combat bone loss in spine and hips.

Femtech Insider reports on Osteoboost, the first FDA-cleared wearable device offering a non-drug solution for low bone density treatment.

San Francisco Business Times covers Osteoboost, a vibrating belt by Bone Health Technologies, aiding postmenopausal women in preserving bone density.

eMPR announces the availability of Osteoboost, an FDA-cleared wearable delivering targeted vibration therapy to strengthen bones in postmenopausal women.

ODTmag announces the U.S. launch of Osteoboost, an FDA-cleared wearable delivering targeted vibration therapy to strengthen bones in spine and hips.

Longevity.Technology reports on Osteoboost, an FDA-cleared wearable delivering at-home vibration therapy to combat bone loss in postmenopausal women.